Exposure to selective noradrenalin reuptake inhibitors during the first trimester of pregnancy and risk of congenital malformations: A meta-analysis of cohort studies

Ankarfeldt, 2021, Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: a nationwide cohort study in Denmark and Sweden, PLoS Med., 18, 10.1371/journal.pmed.1003851 Bérard, 2016, The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis, Br. J. Clin. Pharmacol., 81, 589, 10.1111/bcp.12849 Bérard, 2017, Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort, BMJ Open, 7, 10.1136/bmjopen-2016-013372 Binnewies, 2021, Associations between depression, lifestyle and brain structure: a longitudinal MRI study, Neuroimage, 231, 10.1016/j.neuroimage.2021.117834 Chisolm, 2016, Management of psychotropic drugs during pregnancy, BMJ, 532, h5918, 10.1136/bmj.h5918 Dalmizrak, 2016, Fluoxetine-induced toxicity results in human placental glutathione S-transferase-π (GST-π) dysfunction, Drug Chem. Toxicol., 39, 439, 10.3109/01480545.2016.1141422 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Einarson, 2001, Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study, Am. J. Psychiatry, 158, 1728, 10.1176/appi.ajp.158.10.1728 Furu, 2015, Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design, BMJ, 350, h1798, 10.1136/bmj.h1798 Gao, 2017, Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies, Br. J. Clin. Pharmacol., 83, 2134, 10.1111/bcp.13321 Gao, 2018, Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births, BMC Med., 16, 205, 10.1186/s12916-018-1193-5 Gelaye, 2016, Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries, Lancet Psychiatry, 3, 973, 10.1016/S2215-0366(16)30284-X Heikkine, 2002, Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta, BJOG, 109, 1003, 10.1111/j.1471-0528.2002.01467.x Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Huybrechts, 2014, Antidepressant use in pregnancy and the risk of cardiac defects, N. Engl. J. Med., 370, 2397, 10.1056/NEJMoa1312828 Huybrechts, 2020, Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study, BMJ, 368, m237, 10.1136/bmj.m237 Jahan, 2021, Untreated depression during pregnancy and its effect on pregnancy outcomes: a systematic review, Cureus, 13, e17251 Kempny, 2014, Antidepressant use in pregnancy and the risk of cardiac defects, N. Engl. J. Med., 371, 1167, 10.1056/NEJMc1409203 Kolding, 2021, Antidepressant use in pregnancy and severe cardiac malformations: danish register-based study, BJOG, 128, 1949, 10.1111/1471-0528.16772 Kummer, 2021, The conscientiousness-health link in depression: results from a path analysis, J. Affect. Disord., 295, 1220, 10.1016/j.jad.2021.09.017 Kupfer, 2012, Major depressive disorder: new clinical, neurobiological, and treatment perspectives, Lancet, 379, 1045, 10.1016/S0140-6736(11)60602-8 Lassen, 2016, First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review, Basic Clin. Pharmacol. Toxicol., 118, 32, 10.1111/bcpt.12497 Lau, 2006, The case of the misleading funnel plot, BMJ, 333, 597, 10.1136/bmj.333.7568.597 Laurent, 2016, In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat, Birth Defects Res. A Clin. Mol. Teratol., 106, 1044, 10.1002/bdra.23537 Mandrioli, 2018, New-generation, Non-SSRI antidepressants: therapeutic drug monitoring and pharmacological interactions. Part 1: sNRIs, SMSs, SARIs, Curr. Med. Chem., 25, 772, 10.2174/0929867324666170712165042 Ornoy, 2017, Selective serotonin reuptake inhibitors during pregnancy: do we have now more definite answers related to prenatal exposure?, Birth Defects Res., 109, 898, 10.1002/bdr2.1078 Richardson, 2019, Pregnancy outcomes following maternal venlafaxine use: a prospective observational comparative cohort study, Reprod. Toxicol., 84, 108, 10.1016/j.reprotox.2019.01.003 Sadler, 2011, Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations, Reprod. Toxicol., 32, 484, 10.1016/j.reprotox.2011.09.004 Sari, 2003, Serotonin and its transporter on proliferation of fetal heart cells, Int. J. Dev. Neurosci., 21, 417, 10.1016/j.ijdevneu.2003.10.002 Schueler, 2011, A systematic review of duloxetine and venlafaxine in major depression, including unpublished data, Acta Psychiatr. Scand., 123, 247, 10.1111/j.1600-0447.2010.01599.x Shen, 2017, Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies, Br. J. Clin. Pharmacol., 83, 909, 10.1111/bcp.13161 Stein, 2014, Effects of perinatal mental disorders on the fetus and child, Lancet, 384, 1800, 10.1016/S0140-6736(14)61277-0 Thompson, 2022, The antidepressant venlafaxine perturbs cardiac development and function in larval zebrafish, Aquat. Toxicol., 242, 10.1016/j.aquatox.2021.106041 Uguz, 2020, Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses, Expert Opin. Drug Saf., 19, 1595, 10.1080/14740338.2020.1832080 Warkus, 2018, Fluoxetine Inhibits Canonical Wnt Signaling to Impair Embryoid Body Morphogenesis: potential Teratogenic Mechanisms of a Commonly Used Antidepressant, Toxicol. Sci., 165, 372, 10.1093/toxsci/kfy143 Wells G, Shea B, O'Connell D, et al. 2021. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality If Nonrandomised Studies in Meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed 22 March 2021). Yavarone, 1993, Serotonin and cardiac morphogenesis in the mouse embryo, Teratology, 47, 573, 10.1002/tera.1420470609